I Peace
Kyoto, JP · Founded 2015 · 1 known investors
Find your way into I Peace
Sign up to see every warm intro you have to I Peace
- Paths you didn't know you had: your email and LinkedIn already hold routes to the I Peace team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.
Founders & leadership
I Peace was founded in 2015 by Koji Tanabe and Tsuyoshi Tanabe.

Board
Investors · 1
How we know: Hitachi Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.1M disclosed across 5 rounds · 2016–2024
▶$9.7MraisedFeb 2025 · 3 investors · Other TechnologyRule 506(b)
- Hideya HayashiDirector
- James PrentonExecutive Officer
- Koji TanabeExecutive Officer, Director
- Tsunesaburo SugayaExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $9.7M
- First sale
- Oct 2024
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$8.5MraisedNov 2024 · 2 investors · Other TechnologyRule 506(b)
- Koji TanabeExecutive Officer, Director
- James PrentonExecutive Officer
- Tsunesaburo SugayaExecutive Officer, Director
- Hideya HayashiDirector
- Offering amount
- $16M
- Amount sold
- $8.5M
- First sale
- Oct 2024
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$17.8MraisedJun 2021 · 7 investors · Other TechnologyRule 506(b)
- Koji TanabeExecutive Officer, Director
- James PrentonExecutive Officer
- Tsunesaburo SugayaExecutive Officer, Director
- Hideya HayashiDirector
- Offering amount
- $20.8M
- Amount sold
- $17.8M
- First sale
- Jun 2021
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$6MraisedMar 2017 · 3 investors · BiotechnologyRule 506(b)
- Hideya HayashiDirector
- James PrentonExecutive Officer
- Koji TanabeExecutive Officer, Director
- Tsunesaburo SugayaExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Dec 2016
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06b
▶$5.1MraisedJan 2016 · 4 investors · BiotechnologyRule 506(b)
- James PrentonExecutive Officer
- Tsunesaburo SugayaExecutive Officer, Director
- Offering amount
- $5.1M
- Amount sold
- $5.1M
- First sale
- Jan 2016
- Incorporated
- Corporation, California, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does I Peace do?
- iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.
- Who founded I Peace?
- I Peace was founded by Koji Tanabe, Tsuyoshi Tanabe in 2015.
- Who are I Peace's investors?
- I Peace's investors include Hitachi Ventures.
- How much funding has I Peace raised?
- I Peace has disclosed $47.1M raised across 5 rounds.
- Where is I Peace headquartered?
- I Peace is headquartered in Kyoto, JP.

